tretazicar has been researched along with Prostatic Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Ay, M; Çelik, A; Gülhan, ÜG; Güngör, T; Hacıoğlu, N; Köçkar, F; Önder, FC; Tok, TT; Tokay, E | 1 |
| Ay, M; Çelik, A; Güngör, T; Güven Gülhan, Ü; Hacıoğlu, N; Köçkar, F; Tokay, E | 1 |
| Ashdown, D; Bonney, S; Chester, J; Collins, SI; Doherty, A; Hull, D; James, ND; Leung, H; Mautner, V; Patel, P; Peers, E; Pineda, RG; Searle, PF; Wallace, DM; Young, JG; Young, LS | 1 |
| James, N; Mautner, V; Onion, D; Patel, P; Pineda, RG | 1 |
| Masai, M; Sato, N | 1 |
| Bangma, CH; Irvine, AS; Kraaij, R; Lipinski, KS; Mills, KH; Mountain, A; Pelech, S; Todryk, SM | 1 |
| Green, NK; James, ND; Mautner, V; Searle, PF; Young, JG; Young, LS | 1 |
| James, ND; Latham, JP; Mautner, V; Searle, PF | 1 |
| Djeha, AH; Harris, PA; Kerr, DJ; Leung, H; Mountain, A; Searle, PF; Thomson, TA; Wrighton, CJ; Young, LS | 1 |
1 review(s) available for tretazicar and Prostatic Neoplasms
| Article | Year |
|---|---|
[The trends in new drugs for the prostate cancer].
Topics: Adenoviridae; Androgen Antagonists; Antibodies, Monoclonal; Antineoplastic Agents; Aziridines; Cancer Vaccines; Drug Design; Flurbiprofen; Genetic Therapy; Genetic Vectors; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Oligonucleotides, Antisense; Panitumumab; Prostate-Specific Antigen; Prostatic Neoplasms | 2002 |
2 trial(s) available for tretazicar and Prostatic Neoplasms
| Article | Year |
|---|---|
A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984].
Topics: Adenoviridae; Aged; Aged, 80 and over; Antineoplastic Agents; Aziridines; Genetic Therapy; Genetic Vectors; Humans; Male; Middle Aged; Nitroreductases; Prodrugs; Prostatic Neoplasms | 2009 |
Antivector and tumor immune responses following adenovirus-directed enzyme prodrug therapy for the treatment of prostate cancer.
Topics: Adenoviridae; Aziridines; Enzyme-Linked Immunosorbent Assay; Genes, Transgenic, Suicide; Genetic Therapy; Genetic Vectors; Humans; Interferon-gamma; Male; Nitroreductases; Prodrugs; Prostate-Specific Antigen; Prostatic Neoplasms; T-Lymphocytes | 2009 |
6 other study(ies) available for tretazicar and Prostatic Neoplasms
| Article | Year |
|---|---|
Prodrugs for nitroreductase-based cancer therapy-3: Antitumor activity of the novel dinitroaniline prodrugs/Ssap-NtrB enzyme suicide gene system: Synthesis, in vitro and in silico evaluation in prostate cancer.
Topics: Aniline Compounds; Antineoplastic Agents; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Genetic Therapy; Humans; Male; Models, Molecular; Molecular Structure; Nitroreductases; Prodrugs; Prostatic Neoplasms; Structure-Activity Relationship | 2020 |
Prodrugs for nitroreductase based cancer therapy-4: Towards prostate cancer targeting: Synthesis of N-heterocyclic nitro prodrugs, Ssap-NtrB enzymatic activation and anticancer evaluation.
Topics: Antineoplastic Agents; Aziridines; Colletotrichum; Complex Mixtures; Drug Screening Assays, Antitumor; Enzyme Activation; Enzyme Inhibitors; Fermentation; Fused-Ring Compounds; Heterocyclic Compounds; Humans; Male; Nitro Compounds; Nitroreductases; Polyketides; Prodrugs; Prostatic Neoplasms; Structure-Activity Relationship | 2020 |
Nitroreductase-based therapy of prostate cancer, enhanced by raising expression of heat shock protein 70, acts through increased anti-tumour immunity.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Aziridines; Cell Line, Tumor; Genetic Therapy; Genetic Vectors; HSP70 Heat-Shock Proteins; Immunotherapy; Male; Mice; Mice, Inbred C57BL; Necrosis; Nitroreductases; Prostatic Neoplasms; Proteomics | 2006 |
Combining gene and immunotherapy for prostate cancer.
Topics: Adenocarcinoma; Adenoviridae; Animals; Antineoplastic Agents; Aziridines; Biotransformation; Combined Modality Therapy; Defective Viruses; Escherichia coli Proteins; Genes, Synthetic; Genes, Transgenic, Suicide; Genetic Therapy; Genetic Vectors; Granulocyte-Macrophage Colony-Stimulating Factor; Immunotherapy; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Transplantation; Nitroreductases; Prodrugs; Prostatic Neoplasms; Recombinant Proteins; Specific Pathogen-Free Organisms | 2008 |
Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Topics: Adenoviridae; Androgens; Antineoplastic Agents; Aziridines; Cell Survival; Colonic Neoplasms; Coloring Agents; Cytomegalovirus; Enhancer Elements, Genetic; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; Humans; Jurkat Cells; Kinetics; Luciferases; Luminescent Proteins; Male; Oxazines; Polymerase Chain Reaction; Prodrugs; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Recombinant Fusion Proteins; Tissue Kallikreins; Transfection; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Xanthenes | 2000 |
Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: a well-tolerated therapy for established solid tumors.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Aziridines; Carcinoma, Hepatocellular; Colorectal Neoplasms; Dose-Response Relationship, Drug; Escherichia coli; Gene Transfer Techniques; Genetic Therapy; Head and Neck Neoplasms; Humans; Liver Neoplasms; Luciferases; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Nitroreductases; Prodrugs; Prostatic Neoplasms; Transduction, Genetic; Transfection; Tumor Cells, Cultured | 2001 |